Physician profile
Michael H Smith
NPI 1225132897
$2,218.64
in general payments reported to CMS, 2019-2025
23 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $182 · 2021: $531 · 2022: $485 · 2023: $323 · 2024: $289 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $607.43 | 2019-2024 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $265.93 | 2019-2025 | Veozah |
| Daiichi Sankyo INC. | $243.38 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $239.20 | 2021-2025 | |
| Myovant Sciences INC. | $122.43 | 2021-2022 | |
| Organon LLC | $105.73 | 2021-2024 | |
| Hologic Sales and Service, LLC | $96.54 | 2021-2024 | Thinprep 2000 Processor, Aptima, Novasure |
| Mylan Pharmaceuticals INC. | $69.97 | 2019-2021 | |
| Allergan, INC. | $66.60 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $43.19 | 2019-2021 | |
| Urovant Sciences INC | $43.11 | 2021 | |
| Ethicon US, LLC | $39.47 | 2022-2025 | Ethicon, Surgicel Nu-Knit, Stratafix |
| Pfizer INC. | $36.48 | 2020 | |
| Gynesonics, INC. | $35.34 | 2022 | |
| Therapeuticsmd, INC. | $34.23 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $31.86 | 2023-2025 | Pico |
| Sumitomo Pharma America, INC. | $23.87 | 2024 | Myfembree |
| Avanos Medical | $22.06 | 2019 | |
| Novo Nordisk INC | $21.44 | 2023 | Wegovy |
| Conmed Corporation | $19.19 | 2025 | Vcare |
| Roche Diagnostics Corporation | $18.98 | 2019 | |
| Exeltis, USA INC. | $18.37 | 2025 | Slynd |
| Avion Pharmaceuticals | $13.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.